Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold.
Oral antihistamine‐decongestant‐analgesic combinations for the common cold – Cochrane Library Commentary: Oral antihistamine-decongestant-analgesic combinations for the common cold – Cochrane Library
The post Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold. appeared first on Links Medicus.
A registry study with 1,581 cases of Stenotrophomonas maltophilia blood and/or lower respiratory infections suggest Levofloxacin is a reasonable alternative to standard therapy with Trimethoprim-sulfamethoxazole.
Trimethoprim-Sulfamethoxazole versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 U.S. Hospitals – Open Forum Infectious Diseases Commentary on Twitter A new study in OFID suggests that mortality outcomes are similar comparing levofloxacin and TMP/SMX treatment of S. maltophilia lower respiratory tract and bloodstream infections. ?:https://t.co/80QDy3DTU9 #IDSAJournals @PaulSaxMD @DrJLi @Keith_S_Kaye […]
The post A registry study with 1,581 cases of Stenotrophomonas maltophilia blood and/or lower respiratory infections suggest Levofloxacin is a reasonable alternative to standard therapy with Trimethoprim-sulfamethoxazole. appeared first on Links Medicus.
RCT: Acetazolamide prevents adverse altitude effects in COPD and healthy adults.
Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults – NEJM Evidence Related: A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention
The post RCT: Acetazolamide prevents adverse altitude effects in COPD and healthy adults. appeared first on Links Medicus.
RCT: Electronic directly observed therapy is noninferior to in-person observed therapy for ensuring adherence to tuberculosis treatment.
In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial – JAMA Network Open Commentary on Twitter In this 2-year study, data showed that electronic directly observed therapy (eDOT) was as effective as traditional in-person DOT for ensuring high adherence to treatment of tuberculosis disease. @CDC_TB @nycHealthy @ColumbiaMed https://t.co/yTrU1JRuwn pic.twitter.com/QXthE4d266 […]
The post RCT: Electronic directly observed therapy is noninferior to in-person observed therapy for ensuring adherence to tuberculosis treatment. appeared first on Links Medicus.
Cohort study: Among patients who survived ICU treatment for COVID-19, 75% still reported physical, mental, or cognitive symptoms after 1 year.
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19 – JAMA Commentaries: 75% of COVID ICU survivors have physical symptoms 1 year on – CIDRAP Majority of COVID-19 survivors experience health problems one-year post ICU admission – News Medical
The post Cohort study: Among patients who survived ICU treatment for COVID-19, 75% still reported physical, mental, or cognitive symptoms after 1 year. appeared first on Links Medicus.
[Preprint] Omicron SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta.
Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2) – medRxiv Commentary on Twitter In Portugal, Omicron hospitalizations were 75% reduced compared with Delta, risk adjusted. Vaccination reduced hospitalizations 84%, w/a booster 93%https://t.co/MvkfuF3mzx pic.twitter.com/zyk2INWNis — Eric Topol (@EricTopol) January 23, 2022
The post [Preprint] Omicron SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta. appeared first on Links Medicus.
[Preprint] Cohort study: Reduced risk of hospitalization associated with infection with SARS-CoV-2 Omicron relative to Delta.
Reduced Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Relative to Delta: A Danish Cohort Study – SSRN / Preprints with The Lancet Commentaries: Danish report: lower risk of hospitalisation with Omicron – Copenhagen Post Omicron has a 36% lower risk for hospitalization compared to Delta: Denmark study – Outbreak News Today Commentary […]
The post [Preprint] Cohort study: Reduced risk of hospitalization associated with infection with SARS-CoV-2 Omicron relative to Delta. appeared first on Links Medicus.
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa.
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study – The Lancet Commentary: Omicron severity: milder but not mild – The Lancet Commentary on Twitter Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in S. Africa, Lancet. Individuals with Omicron vs previous […]
The post Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa. appeared first on Links Medicus.
WHO drops opposition to boosters – recommends third Pfizer jab for adults & two vaccines for children ages 5 & up.
WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up – Health Policy Watch Related: WHO updated roadmap for prioritizing uses of COVID-19 vaccines. WHO advisers weigh in on COVID-19 boosters, Pfizer vaccine in younger kids.
The post WHO drops opposition to boosters – recommends third Pfizer jab for adults & two vaccines for children ages 5 & up. appeared first on Links Medicus.
ACP living, rapid review: risk for reinfection after SARS-CoV-2.
Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection – Annals of Internal Medicine Commentary on Twitter Risk for Reinfection After #SARSCoV2: previous infection reduced risk for reinfection by 87% (95% CI, 84% to […]
The post ACP living, rapid review: risk for reinfection after SARS-CoV-2. appeared first on Links Medicus.